Impact and prognostic implications of colon cancers stage II sub-classification through the years

被引:12
作者
Lorenzon, Laura [1 ]
Pilozzi, Emanuela [2 ]
La Torre, Marco [1 ]
Ziparo, Vincenzo [1 ]
Ferri, Mario [1 ]
机构
[1] Univ Roma La Sapienza, St Andrea Hosp, Fac Med & Psychol, Surg & Med Dept Clin Sci Biomed Technol & Transla, I-00189 Rome, Italy
[2] Univ Roma La Sapienza, St Andrea Hosp, Fac Med & Psychol, Dept Clin & Mol Med, I-00189 Rome, Italy
关键词
Colon cancer; T4; Stage II; Colon cancer staging; AJCC 7th edition; ADJUVANT RECTAL-CANCER; COLORECTAL-CANCER; FOLLOW-UP; CHEMOTHERAPY; SURVIVAL; THERAPY; RELAPSE;
D O I
10.1007/s00384-012-1475-x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
According to the American Joint Committee on Cancer (AJCC) 7th edition, T4 colon cancers have been sub-divided into T4a and T4b, resulting in a stage II sub-classification (T3N0, T4aN0, and T4bN0). This study was aimed: (a) to investigate the impact of the AJCC 7th edition stage II sub-classification on the overall survival (OS), disease-free survival (DFS) and disease-specific survival (DSS) of colon cancer patients who underwent surgical resection and (b) to compare the last three AJCC editions for identifying stage II patients with high-risk of progression. One hundred seventy-eight stage II colon cancers out of 682 colorectal cancer patients who underwent surgical resection were selected. T4N0 were sub-divided in accordance with the AJCC 7th edition. Mean follow-up was 41.9 months. Kaplan-Meier method was employed to estimate the survival curves. OS analysis documented a significant difference between stage-sub-groups using the 6th edition; conversely, this difference was not seen if the 7th edition was applied (p = 0.03 and 0.12, respectively). Stage II DFS analysis reported a significant difference using both the AJCC 6th and 7th editions (p = 0.03 and 0.02, respectively). A significant difference was reported on stage II DSS analysis using the AJCC 6th edition (p = 0.03); however, when the 7th edition was applied, a substantial discrepancy between survival curves was noted with T3N0 and T4aN0 displaying similar outcomes (p = 0.006). The AJCC 7th edition is a reliable classification that might implement the identification of those stage II colon cancer patients with high-risk of progression, recurrence, and cancer mortality.
引用
收藏
页码:1311 / 1318
页数:8
相关论文
共 24 条
[1]
American Joint Committee on Cancer, 2009, MAN STAG CANC
[2]
American Joint Committee on Cancer, 1983, MAN STAG CANC
[3]
[Anonymous], 1997, MAN STAG CANC
[4]
[Anonymous], Clinical practice guidelines in oncology
[5]
[Anonymous], MAN STAG CANC
[6]
[Anonymous], MAN STAG CANC
[7]
[Anonymous], TNM CLASSIFICATION M
[8]
[Anonymous], MAN STAG CANC
[9]
American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer [J].
Benson, AB ;
Schrag, D ;
Somerfield, MR ;
Cohen, AM ;
Figueredo, AT ;
Flynn, PJ ;
Krzyzanowska, MK ;
Maroun, J ;
McAllister, P ;
Van Cutsem, E ;
Brouwers, M ;
Charette, M ;
Haller, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3408-3419
[10]
Compton C, 2000, CANCER-AM CANCER SOC, V88, P1739, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO